Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: Improvement after short-term inotropic support

Clinical Science

Volumn 110, Issue 4, 2006, Pages 483-489

  White, Michel ^a   Ducharme, Anique ^a   Ibrahim, Reda ^a   Whittom, Lucette ^a   Lavoie, Joel ^a   Guertin, Marie Claude ^a   Racine, Normand ^a   He, Ying ^b   Yao, Guoying ^b   Rouleau, Jean L ^a   Schiffrin, Ernesto L ^b   Touyz, Rhian M ^b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Adhesion molecule; Cytokine; Dobutamine; Heart failure; Inflammation; Milrinone; Oxidative stress

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; DOBUTAMINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INOTROPIC AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MILRINONE; MONOCYTE CHEMOTACTIC PROTEIN 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLORIMETRY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DETERIORATION; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INOTROPISM; MEDIATOR RELEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT DURATION; WALKING;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOTONIC AGENTS; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHEMOKINE CCL2; COLORIMETRY; CYTOKINES; DINOPROST; DISEASE PROGRESSION; DOBUTAMINE; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; MILRINONE; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TYROSINE;

EID: 33645562485     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050317     Document Type: Article

References (45)

1. Cotter, G., Moshkovitz, Y., Milovanov, O. et al. (2002) Acute congestive heart failure: a novel approach to its pathogenesis and treatment. Eur. J. Heart Failure 4, 227-234
2. Mann, D. L. (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ. Res. 91, 988-998
3. Ide, T., Tsutsui, H., Kinugawa, S. et al. (2000) Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86, 152-157
4. Malik, I., Danesh, J., Whincup, P. et al. (2001) Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358, 971-975
5. Ferrari, R., Bachetti, T., Confortini, R. et al. (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92, 1479-1486
6. Munger, M. A., Johnson, B., Amber, I. J., Callahan, K. S. and Gilbert, E. M. (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathie. Am. J. Cardiol. 77, 723-727
7. Carlstedt, F., Lind, L. and Lindahl, B. (1997) Proinflammatory cytokines measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J. Intern. Med. 242, 361-365
8. Yamaoka-Tojo, M., Tojo, T., Inomata, T., Machida, Y., Osada, K. and Izumi, T. (2002) Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J. Cardiac Failure 8, 21-27
9. Yndestad, A., Holm, A. M., Müller, F. et al. (2003) Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc. Res. 60, 141-146
10. Kaneko, K., Kanda, T., Yamauchi, Y. et al. (1999) C-reactive protein in dilated cardiomyopathy. Cardiology 91, 215-219
11. Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J. and Tedgui, A. (1998) Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilation and progression in heart failure. Circulation 97, 1536-1539
12. Dhalla, A. K., Hill, M. F. and Singal, P. K. (1996) Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28, 506-514
13. Ferrari, R., Agnoletti, L., Comini, L., Comini, L. and Curello, S. (1998) Oxidative stress during myocardial ischaemia and heart failure. Eur. Heart J. 19, B2-B11
14. Sorescu, D. and Griendling, K. K. (2002) Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest. Heart Failure 8, 132-140
15. Heymes, C., Bendall, J. K., Ratajczak, P. et al. (2003) Increased myocardial NADPH oxidase activity in human heart failure. J. Am. Coll. Cardiol. 41, 2164-2171
16. Vanderheyden, M., Kersschot, E. and Paulus, W. J. (1998) Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. Eur. Heart J. 19, 747-752
17. Castro, P. F., Greig, D., Perez, O. et al. (2003) Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 92, 215-218
18. Berton, G., Cordiano, R., Palmieri, R., Pianca, S., Pagliara, V. and Palatini, P. (2003) C-reactiye protein in acute myocardial infarction: association with heart failure. Am. Heart J. 145, 1094-1101
19. Valgimigli, M., Merli, E., Malagutti, P. et al. (2004) Hydroxyl radical generation, levels of tumor necrosis factor-α, and progression to heart failure after acute myocardial infarction. J. Am. Coll. Cardiol. 43, 2000-2008
20. Hasper, D., Hummel, M., Kleber, F. X., Reindl, I. and Volk, H. D. (1998) Systemic inflammation in patients with heart failure. Eur. Heart J. 63, 237-244
21. Tsutamoto, T., Hisanaga, T., Wada, A. et al. (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure and the high plasma level of interleukin-6 an important prognostic predictor in patients with congestive heart failure. J. Am. Coll. Cardiol. 31, 391-398
22. Levine, B., Kalman, J., Mayer, L., Fillit, H. M. and Packer, M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241
23. Guyatt, G. H., Sullivan, M. J., Thompson, P. J. et al. (1985) The 6-minutes walk; a new measure of exercise capacity in patients with chronic heart failure. Can. Med. Assoc. J. 132, 919-923
24. Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M. and Schiffrin, E. L. (2002) Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 40, 504-510
25. Devaux, B., Scholz, D., Hirche, A., Klovekorn, W. P. and Schaper, J. (1997) Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur. Heart J. 18, 470-479
26. Ridker, P. M. (2003) High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am. J. Cardiol. 92, 17K-22K
27. Brennan, M. L., Penn, M. S., Van Lente, F. et al. (2003) Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349, 1595-1604
28. He, J., Ogden, L. G., Bazzano, L. A., Vupputuri, S., Loria, C. and Whelton, P. K. (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch. Intern. Med. 161, 996-1002
29. Sato, Y., Takatsu, Y., Kataoka, K. et al. (1999) Serial circulating concentrations of C-reactive protein, interleukin (IL-4) and IL-6 in patients with acute heart decompensation. Clin. Cardiol. 22, 811-813
30. Filippatos, G., Parissis, J. T., Adamopoulos, S. and Kardaras, F. (2003) Chemokines in cardiovascular remodeling: clinical and therapeutic implications. Curr. Mol. Med. 3, 139-147
31. Aukrust, P., Ueland, T., Müller, F. et al. (1998) Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97, 1136-1143
32. Blankenberg, S., Tiret, L., Bickel, C. et al. (2002) Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106, 24-30
33. Pomerantz, B. J., Reznikov, L. L., Harken, A. H. and Dinarello, C. A. (2001) Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β. Proc. Natl. Acad. Sci. U.S.A. 98, 2871-2876
34. White, M., Rouleau, J. L., Ruddy, T. D., De Marco, D. and Chatterjee, K. (1991) Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J. Am. Coll. Cardiol. 18, 1631-1637
35. Libby, P. and Ridker, P. M. (1999) Novel inflammatory markers of coronary risk. Theory versus practice. Circulation 100, 1148-1150
36. Andreassen, A. K., Nordoy, I., Simonsen, S. et al. (1998) Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am. J. Cardiol. 81, 604-608
37. Saadeddin, S. M., Habbab, M. A. and Ferns, G. A. (2002) Markers of inflammation and coronary artery disease. Med. Sci. Monit. 8, RA5-RA12
38. Hein, S., Arnon, E., Kostin, S. et al. (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107, 984-991
39. Haque, R., Kan, H. and Finkel, M. S. (1998) Effects of cytokines and nitric oxide on myocardial E-C coupling. Basic Res. Cardiol. 93, 86-94
40. Lalukota, K., Cleland, J. G., Ingle, L., Clark, A. L. and Coletta, A. P. (2004) Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD. Eur. J. Heart Failure 6, 953-955
41. Sasayama, S. (2002) Inotropic agents and immune modulation. Cardiovasc. Drugs Ther. 16, 237-243
42. Takeno, M., Takagi, S., Sakuragi, S. et al. (2002) Continuous milrinone infusion during preoperative anti-inflammatory therapy in inflammatory aortic aneurysm complicating severe congestive heart failure. Heart Vessels 17, 42-44
43. Vasan, R. S., Sullivan, L. M., Roubenoff, R. et al. (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107, 1486-1491
44. Rauchhaus, M., Doehner, W., Francis, D. P. et al. (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102, 3060-3067
45. Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B. and Mann, D. L. (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J. Am. Coll. Cardiol. 27, 1201-1206